In the Media

Maine Technology Institute Fund Research into Peripheral Nerve Damage

RegMedNet · September 15, 2017

The Maine Technology Institute has awarded a $25,000 seed grant to Sandra Rieger, MDI Biological Laboratory, to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet, and affects an estimated 20–40 million Americans.

MTI Awards $25,000 Grant to MDI Biological Laboratory Scientist for Peripheral Neuropathy Research

Medical Life Sciences · September 13, 2017

The Maine Technology Institute has awarded a $25,000 seed grant to Sandra Rieger, Ph.D., of the MDI Biological Laboratory to study peripheral neuropathy, a condition that causes pain, tingling and numbness in the hands and feet and affects an estimated 20 to 40 million Americans.

Hope for Heart Attack Victims

Innovators Magazine · September 12, 2017

An American biosciences firm has been awarded a grant to advance a therapy it claims could be a game-changer for people who have suffered a heart attack.

$1.5M Grant Advances Research of Therapy Drug for Heart Attack Victims

Mainebiz · September 12, 2017

Kevin Strange, CEO of Novo Biosciences and president of MDI Biological Laboratory, and MDI Biological Laboratory scientist Voot P. Yin, to use $1.5 million in federal funding to study the effectiveness of a potential regenerative medicine therapy for heart attack patients.

Regenerative Cardiac Drug Receives Federal Funding

RegMedNet · September 11, 2017

Novo Biosciences Inc. has announced that it has received a $1.5 million grant from the National Institutes of Health for the development of MSI-1436 as a potential regenerative medicine therapy for the treatment of patients who have suffered an acute heart attack.

Novo Biosciences Receives Federal Grant to Advance Potential Heart Drug

Maine Technology Institute · September 8, 2017

Novo Biosciences Inc. has announced that it has received a two-year, $1.5 million grant from the National Institutes of Health for the development of MSI-1436 as a potential regenerative medicine therapy for the treatment of patients who have suffered an acute heart attack.

Bar Harbor Company Gets $1.5 million to Test Heart Attack Drug in Pigs

Central Maine: Kennebec Journal & Morning Sentinel · September 7, 2017

A regenerative medicine company in Bar Harbor received a $1.5 million grant to further its research on treating patients who have suffered acute heart attacks.

Bar Harbor Company Gets $1.5 Million to Test Heart Attack Drug in Pigs

Portland Press Herald · September 7, 2017

Novo Biosciences received a $1.5 million grant from NIH to advance a drug, MSI-1436, that could treat heart attack victims. The grant will allow the company to test the effectiveness of MSI-1436 in a large animal model – the next step in the advancement to clinical trials.

Health Group Giving Maine Firm Grant for Heart Attack Work

San Francisco Chronicle · September 7, 2017

Senator Susan Collins and Senator Angus King say the National Heart, Lung, and Blood Institute is awarding the small business innovation research grant to Novo Biosciences to support research on new treatments for healing damaged heart tissue.

MDI Biological Laboratory Summer Program Puts 32 Undergrads in Labs

Mainebiz · August 31, 2017

The MDI Biological Laboratory put 32 interns in research and lab facilities across the state, 20 of the participants supported by Maine INBRE, a network of 13 Maine educational and research institutions led by the laboratory.

Older ❯